2.2. Analysis.

Comparison 2: Triple therapy versus LABA/LAMA combination – Exclude Papi 2018, Outcome 2: Moderate‐to‐severe exacerbations (Time‐to‐first)

Comparison 2: Triple therapy versus LABA/LAMA combination – Exclude Papi 2018, Outcome 2: Moderate‐to‐severe exacerbations (Time‐to‐first)